CV Sciences (CVSI) EBT (QoQ) (2011 - 2026)
CV Sciences (CVSI) EBT (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.75% |
| Mar 31, 2026 | -494.48% |
| Dec 31, 2025 | 142.67% |
| Sep 30, 2025 | -46.36% |
| Jun 30, 2025 | -155.88% |
| Mar 31, 2025 | 78.71% |
| Dec 31, 2024 | -5.04% |
| Sep 30, 2024 | 21.92% |
| Jun 30, 2024 | 6.11% |
| Mar 31, 2024 | 29.16% |
| Dec 31, 2023 | -96.42% |
| Sep 30, 2023 | 65.21% |
| Jun 30, 2023 | -122.52% |
| Mar 31, 2023 | 341.57% |
| Dec 31, 2022 | -129.10% |
| Sep 30, 2022 | 61.11% |
| Jun 30, 2022 | -25.34% |
| Mar 31, 2022 | 76.38% |
| Dec 31, 2021 | -22,287.50% |
| Sep 30, 2021 | 98.86% |